GlobeNewsWire
20 Nov 2025, 13:00 UTC · 47w ago
Verdict
Headline takes no side. We score HUMA +1.00 — strongly bullish.
+1.00strongly bullish
More positive than 99% of ticker scores this week
Which stocks this story touches
More positive than 99% of ticker scores this week
The company reported positive clinical outcomes, successful recellularization of its ATEV product, and durable results across multiple patient groups.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Proactive Investors
5h ago
−66.3%
Price is moving against the score
$0.3948 vs $1.17 close before publication (Nov 19) · not market-adjusted
HUMA chart →
